RDY$14.140.25%-0.035
After Hours: 14.13-0.00 -0.04%
Dr Reddys Laboratories Ltd Adr (RDY)
Date: 2026-11-02 16:00O: 14.15H: 14.20L: 14.05C: 14.14Vol: 1.656M
Dr Reddys Laboratories Ltd Adr stock is traded at $14.14, with a volume of 1,656,253. It is down -0.25% in the last 24 hours and up +15.39% over the past month. Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Previous Close:
$14.17
Open:
$14.15
24h Volume:
1,656,253
Relative Volume:
0.50
Market Cap:
$11.78B
Revenue:
$3.81B
Net Income/Loss:
$485.75M
P/E Ratio:
24.07
EPS:
$0.5873
Net Cash Flow:
$175.50M
1W Performance:
+2.80%
1M Performance:
+15.39%
6M Performance:
+3.02%
1Y Performance:
+6.36%
1-Day Range:
$14.05$14.20
1-Week Range:
$13.62$14.33
52-Week Range:
$11.36$15.67
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
Compare RDY vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
RDY Dr Reddys Laboratories Ltd Adr | $11.78B | $3.81B | $485.75M | $175.50M | $0.5873 |
 TAK Takeda Pharmaceutical Co Adr | $66.71B | $29.91B | $1.30B | $3.49B | $0.4056 |
 TEVA Teva Pharmaceutical Industries Ltd Adr | $47.47B | $14.10B | $706.00M | $1.35B | $1.35 |
 HLN Haleon Plc Adr | $38.59B | $14.54B | $2.22B | $2.58B | $0.4871 |
 ZTS Zoetis Inc | $34.38B | $9.52B | $2.62B | $2.37B | $6.04 |
 UTHR United Therapeutics Corp | $25.55B | $3.15B | $1.31B | $1.09B | $27.09 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
Dr Reddys Laboratories Ltd Adr Stock (RDY) Financials Data
There is no financial data for Dr Reddys Laboratories Ltd Adr (RDY). Check out other stocks for more information.
Dr Reddys Laboratories Ltd Adr Stock (RDY) Insider Trading
- EREZ ISRAELIOct 29 '26CEO
- Transaction
- Proposed Sale
- Cost
- $14.20
- #Shares
- 460,726
- Value ($)
- 6,542,310
- #Shares Total
- 0
